prikaz prve stranice dokumenta The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015
  Download
PDF 899.7 KB
Scientific paper - Original scientific paper
The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015
Expert Review of Pharmacoeconomics & Outcomes Research, 18 (2018), 6; 641-646. https://doi.org/10.1080/14737167.2018.1507820
Potočnjak, Ines; Likić, Robert; Degoricija, Vesna; Nham, Eric; Wettermark, Björn

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Potočnjak, I., Likić, R., Degoricija, V., Nham, E. & Wettermark, B. (2018). The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015. Expert Review of Pharmacoeconomics & Outcomes Research, 18. (6), 641-646. doi: 10.1080/14737167.2018.1507820

Potočnjak, Ines, et al. "The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015." Expert Review of Pharmacoeconomics & Outcomes Research, vol. 18, no. 6, 2018, pp. 641-646. https://doi.org/10.1080/14737167.2018.1507820

Potočnjak, Ines, Robert Likić, Vesna Degoricija, Eric Nham and Björn Wettermark. "The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015." Expert Review of Pharmacoeconomics & Outcomes Research 18, no. 6 (2018): 641-646. https://doi.org/10.1080/14737167.2018.1507820

Potočnjak, I., et al. (2018) 'The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015', Expert Review of Pharmacoeconomics & Outcomes Research, 18(6), pp. 641-646. doi: 10.1080/14737167.2018.1507820

Potočnjak I, Likić R, Degoricija V, Nham E, Wettermark B. The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015. Expert Review of Pharmacoeconomics & Outcomes Research [Internet]. 2018 December [cited 2024 November 09];18(6):641-646. doi: 10.1080/14737167.2018.1507820

I. Potočnjak, R. Likić, V. Degoricija, E. Nham and B. Wettermark, "The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015", Expert Review of Pharmacoeconomics & Outcomes Research, vol. 18, no. 6, pp. 641-646, December 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:735210. [Accessed: 09 November 2024]

Metadata
Title (english)The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015
AuthorInes Potočnjak
AuthorRobert Likić
AuthorVesna Degoricija
AuthorEric Nham
AuthorBjörn Wettermark
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Background: The consumption of psychotropic drugs (PD) is increasing worldwide with a significant variation between countries. Croatia and Sweden have similar health and pharmaceutical systems; however, Sweden is a high-income country with developed medical care, registries, and prescribing guidelines. We sought to compare the utilization of PD between Croatia and Sweden to identify areas for improvement in rational use of drugs. ----- Methods: This was a cross-sectional study using national databases to assess utilization of PD (ATC N05, N06) in Croatia and Sweden in 2014 and 2015. ----- Results: Prescribing of PD in Croatia increased from 127 DDD/TID (defined daily dose/1000 inhabitants) in 2014 to 131 DDD/TID in 2015. In Sweden, the total utilization was higher with an increase from 183 DDD/TID in 2014 to 188 DDD/TID in 2015. There were substantial differences. In Croatia, the utilization of benzodiazepine derivatives (N05BA) was 72.5 DDD/TID in 2014 and increased to 74.4 DDD/TID, in 2015. In Sweden, the utilization was only 11.2 DDD/TID for benzodiazepine derivatives in both years. ----- Conclusions: There were substantial differences in utilization of PD between Croatia and Sweden. Highlighting the problem of inappropriate benzodiazepine utilization in Croatia can help to introduce measures to change prescribing habits and improve prescribing quality.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionAccepted version
Journal titleExpert Review of Pharmacoeconomics & Outcomes Research
Numberingvol. 18, no. 6, pp. 641-646
p-ISSN1473-7167
e-ISSN1744-8379
DOIhttps://doi.org/10.1080/14737167.2018.1507820
URN:NBNurn:nbn:hr:105:735210
Publication2018-12
Document URLhttps://www.tandfonline.com/doi/full/10.1080/14737167.2018.1507820
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2021-02-05 08:42:00